agilon health, inc. provided earnings guidance for the second quarter ending June 30, 2024. For the quarter, the company expects total revenues to be in the range of $1,550 million to $1,570 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.745 USD | -4.09% | +3.94% | -53.78% |
May. 09 | Deutsche Bank Adjusts agilon health Price Target to $5 From $8, Maintains Hold Rating | MT |
May. 07 | Transcript : Agilon health, inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.78% | 2.46B | |
-21.50% | 2.9B | |
-14.05% | 2.9B | |
+1.73% | 222M | |
-42.35% | 194M | |
-55.97% | 193M | |
-40.22% | 103M |
- Stock Market
- Equities
- AGL Stock
- News agilon health, inc.
- Agilon health, inc. Provides Earnings Guidance for the Second Quarter Ending June 30, 2024